AC T08628
AS T08792.
XX
ID T08628
XX
DT 10.03.2005 (created); nvo.
DT 14.04.2014 (updated); jmh.
CO Copyright (C), QIAGEN.
XX
FA POU2F1
XX
SY (Ig)NF-A; alpha-H1; NF-A1; NF-III; OBP100; Oct-1; oct-B1A; oct-B1B; Octamer binding factor 1; octamer-binding factor; OTF-1; POU domain, class 2, transcription factor 1; POU2F1; TRF.
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T08443 AML3; mouse, Mus musculus.
IN T10236 ATF-2; Mammalia.
IN T23082 ATF-4; Mammalia.
IN T15204 brca1; Mammalia.
IN T06595 C/EBPbeta-FL; human, Homo sapiens.
IN T06596 C/EBPbeta-LIP; human, Homo sapiens.
IN T22250 HMG2; mouse, Mus musculus.
IN T10358 HMGIY; Mammalia.
IN T32445 Ku70; Mammalia.
IN T32444 Ku80; Mammalia.
IN T15389 NF-IX; Mammalia.
IN T11027 NFATc3; Mammalia.
IN T16680 OCA-B; Mammalia.
IN T15350 PARP; Mammalia.
IN T10042 Pit-1; Mammalia.
IN T24182 PR; Mammalia.
IN T08433 RXR-alpha; human, Homo sapiens.
IN T19112 SMRT-xbb2; human, Homo sapiens.
IN T10231 Sox-2; Mammalia.
IN T08326 Sp1; Mammalia.
IN T14458 STAT3; Mammalia.
IN T01152 T3R-alpha1; human, Homo sapiens.
IN T14175 TBP; Mammalia.
IN T08482 VDR-isoform1; human, Homo sapiens.
IN T09133 YY1; Mammalia.
IN T14846 ZEB; Mammalia.
XX
MX M00135 V$OCT1_01.
MX M00136 V$OCT1_02.
MX M00137 V$OCT1_03.
MX M00138 V$OCT1_04.
MX M00161 V$OCT1_05.
MX M00162 V$OCT1_06.
MX M00248 V$OCT1_07.
MX M01354 V$OCT1_08.
MX M00342 V$OCT1_B.
MX M00930 V$OCT1_Q5_01.
MX M00195 V$OCT1_Q6.
MX M00210 V$OCT_C.
MX M00795 V$OCT_Q6.
MX M07059 V$POU2F1_Q4_01.
MX M03561 V$POU2F1_Q6.
XX
BS R19771.
BS R19764.
BS R01089.
BS R39263.
BS R14722.
BS R73888.
BS R19770.
BS R72729.
BS R19366.
BS R61301.
BS R25361.
BS R73893.
BS R19050.
BS R73892.
BS R03922.
XX
DR TRANSPATH: MO000047330.
DR TRANSCOMPEL: C00039.
DR TRANSCOMPEL: C00043.
DR TRANSCOMPEL: C00047.
DR TRANSCOMPEL: C00048.
DR TRANSCOMPEL: C00049.
XX
RN [1]; RE0004220.
RX PUBMED: 8202368.
RA Zwilling S., Annweiler A., Wirth T.
RT The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP
RL Nucleic Acids Res. 22:1655-1662 (1994).
RN [2]; RE0005623.
RX PUBMED: 8657574.
RA Schubart D. B., Sauter P., Massa S., Friedl E. M., Schwarzenbach H., Matthias P.
RT Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1
RL Nucleic Acids Res. 24:1913-1920 (1996).
RN [3]; RE0010323.
RX PUBMED: 7720710.
RA Zwilling S., Koenig H., Wirth T.
RT High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors
RL EMBO J. 14:1198-1208 (1995).
RN [4]; RE0023129.
RX PUBMED: 10644678.
RA Aizencang G. I., Bishop D. F., Forrest D., Astrin K. H., Desnick R. J.
RT Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene.
RL J. Biol. Chem. 275:2295-2304 (2000).
RN [5]; RE0031271.
RX PUBMED: 11997177.
RA Gonzalez M. I., Tovaglieri A., Robins D. M.
RT Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct.
RL Mol. Cell. Endocrinol. 190:39-49 (2002).
RN [6]; RE0031471.
RX PUBMED: 14993281.
RA Wang J., Yen A.
RT A novel retinoic acid-responsive element regulates retinoic acid-induced BLR1 expression.
RL Mol. Cell. Biol. 24:2423-43 (2004).
RN [7]; RE0035927.
RX PUBMED: 15798204.
RA Inman C. K., Li N., Shore P.
RT Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.
RL Mol. Cell. Biol. 25:3182-3193 (2005).
RN [8]; RE0036631.
RX PUBMED: 12752447.
RA Liu M., Leibowitz J. L., Clark D. A., Mendicino M., Ning Q., Ding J. W., D'Abreo C., Fung L., Marsden P. A., Levy G. A.
RT Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3
RL Eur. J. Biochem. 270:2274-86 (2003).
RN [9]; RE0036998.
RX PUBMED: 10998423.
RA Fujimori K., Kanaoka Y., Sakaguchi Y., Urade Y.
RT Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. ROLES OF THE oct-1 ELEMENT IN THE 5'-FLANKING REGION AND THE AP-2 ELEMENT IN THE UNTRANSLATED EXON 1
RL J. Biol. Chem. 275:40511-6 (2000).
RN [10]; RE0044051.
RX PUBMED: 7945330.
RA Rosfjord E., Rizzino A.
RT The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells
RL Biochem. Biophys. Res. Commun. 203:1795-802 (1994).
RN [11]; RE0044423.
RX PUBMED: 10744630.
RA Thum T., Haverich A., Borlak J.
RT Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology
RL FASEB J. 14:740-51 (2000).
RN [12]; RE0044612.
RX PUBMED: 11056176.
RA Ma B., Hernandez N.
RT A map of protein-protein contacts within the small nuclear RNA-activating protein complex SNAPc
RL J. Biol. Chem. 276:5027-35 (2001).
RN [13]; RE0044614.
RX PUBMED: 9418884.
RA Wong M. W., Henry R. W., Ma B., Kobayashi R., Klages N., Matthias P., Strubin M., Hernandez N.
RT The large subunit of basal transcription factor SNAPc is a Myb domain protein that interacts with Oct-1
RL Mol. Cell. Biol. 18:368-77 (1998).
RN [14]; RE0044618.
RX PUBMED: 11847120.
RA de Jong R. N., Mysiak M. E., Meijer L. A., van der Linden M., van der Vliet P. C.
RT Recruitment of the priming protein pTP and DNA binding occur by overlapping Oct-1 POU homeodomain surfaces
RL EMBO J. 21:725-35 (2002).
RN [15]; RE0044619.
RX PUBMED: 12414730.
RA Hovde S., Hinkley C. S., Strong K., Brooks A., Gu L., Henry R. W., Geiger J.
RT Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex
RL Genes Dev. 16:2772-7 (2002).
RN [16]; RE0045179.
RX PUBMED: 12133827.
RA Torigoe T., Izumi H., Ishiguchi H., Uramoto H., Murakami T., Ise T., Yoshida Y., Tanabe M., Nomoto M., Itoh H., Kohno K.
RT Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents
RL J. Biol. Chem. 277:36534-43 (2002).
RN [17]; RE0045317.
RX PUBMED: 9705324.
RA Song C. S., Jung M. H., Kim S. C., Hassan T., Roy A. K., Chatterjee B.
RT Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter
RL J. Biol. Chem. 273:21856-66 (1998).
RN [18]; RE0045416.
RX PUBMED: 2007132.
RA Ponce E., Lloyd J. A., Pierani A., Roeder R. G., Lingrel J. B.
RT Transcription factor OTF-1 interacts with two distinct DNA elements in the A gamma-globin gene promoter
RL Biochemistry 30:2961-7 (1991).
RN [19]; RE0045612.
RX PUBMED: 11384994.
RA Zhou H. J., Wong C. M., Chen J. H., Qiang B. Q., Yuan J. G., Jin D. Y.
RT Inhibition of LZIP-mediated transcription through direct interaction with a novel host cell factor-like protein
RL J. Biol. Chem. 276:28933-8 (2001).
RN [20]; RE0046397.
RX PUBMED: 12151092.
RA Zhao F. Q., Adachi K., Oka T.
RT Involvement of Oct-1 in transcriptional regulation of beta-casein gene expression in mouse mammary gland
RL Biochim. Biophys. Acta 1577:27-37 (2002).
RN [21]; RE0047929.
RX PUBMED: 1495986.
RA Lai J. S., Herr W.
RT Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations.
RL Proc. Natl. Acad. Sci. USA 89:6958-6962 (1992).
RN [22]; RE0047933.
RX PUBMED: 10602039.
RA Hatada E. N., Chen-Kiang S., Scheidereit C.
RT Interaction and functional interference of C/EBPbeta with octamer factors in immunoglobulin gene transcription.
RL Eur. J. Immunol. 30:174-184 (2000).
RN [23]; RE0047947.
RX PUBMED: 11134019.
RA Kakizawa T., Miyamoto T., Ichikawa K., Takeda T., Suzuki S., Mori J., Kumagai M., Yamashita K., Hashizume K.
RT Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor.
RL J. Biol. Chem. 276:9720-9725 (2001).
RN [24]; RE0047948.
RX PUBMED: 10383413.
RA Kakizawa T., Miyamoto T., Ichikawa K., Kaneko A., Suzuki S., Hara M., Nagasawa T., Takeda T., Mori J., Kumagai M., Hashizume K.
RT Functional interaction between Oct-1 and retinoid X receptor.
RL J. Biol. Chem. 274:19103-19108 (1999).
RN [25]; RE0047949.
RX PUBMED: 12887926.
RA Zheng L., Roeder R. G., Luo Y.
RT S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component.
RL Cell 114:255-266 (2003).
RN [26]; RE0050737.
RX PUBMED: 17700520.
RA Maekawa T., Sano Y., Shinagawa T., Rahman Z., Sakuma T., Nomura S., Licht J. D., Ishii S.
RT ATF-2 controls transcription of Maspin and GADD45alpha genes independently from p53 to suppress mammary tumors.
RL Oncogene 27:1045-1054 (2007).
RN [27]; RE0054660.
RX PUBMED: 15537384.
RA Roger T., Miconnet I., Schiesser A. L., Kai H., Miyake K., Calandra T.
RT Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression.
RL Biochem. J. 387:355-365 (2005).
XX
//